TCW Group
MDLN icon

TCW Group’s Medline Inc MDLN Stock Holding History

TCW Group’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$235K Buy
+6,760
New +$247K ﹤0.01% 581

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
H&F Corporate Investors X
H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

TCW Group's MDLN Position: Q3 2026 in Review

TCW Group opened a new position in Medline Inc (MDLN) in Q3 2026: 6,760 shares worth $235K. The stake represents ﹤0.01% of the portfolio and ranks #581 among its holdings.

315 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • TCW Group held 6,760 shares of Medline Inc worth $235K as of Q3 2026.
  • Medline Inc was a new TCW Group position in Q3 2026.
  • Medline Inc made up ﹤0.01% of TCW Group's portfolio in Q3 2026, its #581 holding.
  • 315 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on TCW Group's 13F filing for Q3 2026, filed 10 Nov 2026.